Clinical Trial Update: A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating OPC-41061 in adults with chronic renal failure on dialysis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Failure

Drugs mentioned

• OPC-41061

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Chronic Renal Failure | Phase 2 | Status: COMPLETED | Results posted: 2018-08-24